why choose us

First received: September 20, 2024

Clinical Trial: Bioequivalence Test of Hemay005 Tablets

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Psoriasis

Study Type: INTERVENTIONAL


Official Title: Study Protocol for a Single-center, Randomized, Open-label, Two-formulation, Single-dose, Two-cycle, Double-crossover Fasting Bioequivalence Trial of Hemay005 Tablets in Healthy Subjects

Brief Summary: The pharmacokinetics behavior of the test formulation T1 and the control formulation T2 were evaluated by oral administration in healthy subjects under fasting state to evaluate the bioequivalence of the two formulations.

Read more